Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: A health economics analysis of the ASTER trial from a European perspective

Thorax

Volumn 69, Issue 7, 2014, Pages 679-681

  Rintoul, Robert C ^a   Glover, Matthew J ^b   Jackson, Christopher ^c   Hughes, Victoria ^a   Tournoy, Kurt G ^d,e   Dooms, Christophe ^f   Annema, Jouke T ^g,h   Sharples, Linda D ^a,c,i  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e Department of Respiratory Medicine Onze Lieve Vrouwziekenhuis ^*  (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BELGIUM; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC ECHOGRAPHY; HEALTH ECONOMICS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDIASTINUM METASTASIS; NETHERLANDS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORACOTOMY; UNITED KINGDOM;

BRONCHOSCOPY; HEALTH ECONOMIST; LUNG CANCER; NON-SMALL CELL LUNG CANCER; THORACIC SURGERY;

BAYES THEOREM; BELGIUM; COST-BENEFIT ANALYSIS; ENDOSONOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; NETHERLANDS; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84902245936     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-204374     Document Type: Article

References (5)

1. Annema JT, van Meerbeeck JP, Rintoul RC, et al. Mediastinoscopy versus endosonography for mediastinal lymph node staging of lung cancer: a randomised trial. JAMA 2010;304:2245-52.
2. Sharples LD, Jackson C, Wheaton E, et al. Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial. Health Technol Assess 2012;16:1-75.
3. Kind P. The EuroQoL instrument: an index of health-related quality of life. In: Spilker B,ed. Quality of Life and Pharmacoeconomics in Clinical Trials, Second Edition. Philadelphia, PA: Lippincott-Raven Publishers, 1996:191-201.
4. Steinfort DP, Liew D, Conron M, et al. Cost benefit of minimally invasive staging of non small cell lung cancer: a decision tree sensitivity analysis. J Thorac Oncol 2010;5:1564-70.
5. National Institute of Health and Care Excellence (NICE). The diagnosis and treatment of lung cancer. Clinical Guideline 121. London: NICE, 2011.